(19)
(11) EP 3 247 330 A1

(12)

(43) Date of publication:
29.11.2017 Bulletin 2017/48

(21) Application number: 16706041.7

(22) Date of filing: 20.01.2016
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 47/38(2006.01)
A61K 31/198(2006.01)
A61K 9/10(2006.01)
A61K 31/195(2006.01)
(86) International application number:
PCT/US2016/014005
(87) International publication number:
WO 2016/118556 (28.07.2016 Gazette 2016/30)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 20.01.2015 US 201562105565 P
30.12.2015 US 201562272922 P

(71) Applicant: AbbVie Inc.
North Chicago, IL 60064 (US)

(72) Inventors:
  • CONJEEVARAM, Rajkumar
    Lake Bluff, Illinois 60044 (US)
  • DEAC, Alexandru
    Skokie, Illinois 60076 (US)
  • HUANG, Ye
    Gurnee, Illinois 60031 (US)
  • MACKEY, Sean E.
    Grayslake, Illinois 60030 (US)
  • MENGES, Randy A.
    Lake Villa, Illinois 60046 (US)
  • ZIMMERMAN, Jayne B.
    Deerfield, Illinois 60606 (US)

(74) Representative: Garner, Stephen et al
Mathys & Squire LLP The Shard 32 London Bridge Street
London SE1 9SG
London SE1 9SG (GB)

   


(54) LEVODOPA AND CARBIDOPA INTESTINAL GEL AND METHODS OF USE